Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-19-141425
Filing Date
2019-05-08
Accepted
2019-05-08 16:17:04
Documents
50
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d646013d10q.htm 10-Q 383658
2 EX-31.1 d646013dex311.htm EX-31.1 6521
3 EX-31.2 d646013dex312.htm EX-31.2 6473
4 EX-32 d646013dex32.htm EX-32 3928
  Complete submission text file 0001193125-19-141425.txt   5790861

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT itci-20190331.xml EX-101.INS 1943671
6 XBRL TAXONOMY EXTENSION SCHEMA itci-20190331.xsd EX-101.SCH 30929
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE itci-20190331_cal.xml EX-101.CAL 32270
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE itci-20190331_def.xml EX-101.DEF 153021
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE itci-20190331_lab.xml EX-101.LAB 319344
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE itci-20190331_pre.xml EX-101.PRE 256222
Mailing Address 430 EAST 29TH STREET NEW YORK NY 10016
Business Address 430 EAST 29TH STREET NEW YORK NY 10016 212-923-3344
Intra-Cellular Therapies, Inc. (Filer) CIK: 0001567514 (see all company filings)

EIN.: 364742850 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36274 | Film No.: 19806818
SIC: 2834 Pharmaceutical Preparations